RegeneRx Biopharmaceuticals (OTCMKTS:RGRX) Shares Cross Below Fifty Day Moving Average of $0.14

RegeneRx Biopharmaceuticals, Inc. (OTCMKTS:RGRXGet Rating)’s share price passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.14 and traded as low as $0.13. RegeneRx Biopharmaceuticals shares last traded at $0.13, with a volume of 1,100 shares changing hands.

RegeneRx Biopharmaceuticals Stock Up 13.0 %

The stock has a 50 day moving average of $0.14 and a 200-day moving average of $0.15.

RegeneRx Biopharmaceuticals Company Profile

(Get Rating)

RegeneRx Biopharmaceuticals, Inc engages in the development of a novel therapeutic peptide, Thymosin beta 4 for tissue and organ protection, repair, and regeneration. Its product pipeline includes RGN-259, RGN-352, and RGN-137. The company was founded by Allan L. Goldstein on May 13, 1982 and is headquartered in Rockville, MD.

Further Reading

Receive News & Ratings for RegeneRx Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RegeneRx Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.